Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$0.64 - $6.49 $1,683 - $17,068
-2,630 Reduced 18.67%
11,458 $12,000
Q3 2023

Oct 31, 2023

BUY
$6.56 - $10.95 $3,463 - $5,781
528 Added 3.89%
14,088 $97,000
Q2 2023

Jul 19, 2023

SELL
$7.89 - $10.64 $6,469 - $8,724
-820 Reduced 5.7%
13,560 $141,000
Q1 2023

May 12, 2023

BUY
$7.07 - $17.95 $101,666 - $258,121
14,380 New
14,380 $116,000
Q1 2018

May 08, 2018

SELL
$17.08 - $25.64 $138,296 - $207,607
-8,097 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$21.47 - $27.8 $173,842 - $225,096
8,097
8,097 $200,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.